Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Genes|April 28, 2023
How to Choose? Comparing Different Methods to Count Wolf Packs in a Protected Area of the Northern ApenninesArianna Dissegna, Martino Rota, Simone Basile, et al.
Oncotarget|March 25, 2020
Prognostic and predictive factors in pancreatic cancerEmanuela Dell'Aquila, Claudia Angela Maria Fulgenzi, Alessandro Minelli, et al.
Entropy (Basel, Switzerland)|May 28, 2022
Robust Variable-Step Perturb-and-Observe Sliding Mode Controller for Grid-Connected Wind-Energy-Conversion SystemsIlham Toumi, Billel Meghni, Oussama Hachana, et al.
Insects|December 22, 2023
Shallow Whole-Genome Sequencing of <i>Aedes japonicus</i> and <i>Aedes koreicus</i> from Italy and an Updated Picture of Their Evolution Based on Mitogenomics and BarcodingNicola Zadra, Alessia Tatti, Andrea Silverj, et al.
JCO Precision Oncology|April 18, 2025
Exploring the Prognostic and Predictive Impact of Genomic Loss of Heterozygosity and Homologous Recombination Deficiency Alterations in Patients With Metastatic Colorectal CancerRoberto Moretto, Marco Maria Germani, Martina Carullo, et al.
Therapeutic Advances in Medical Oncology|January 8, 2025
Prognostic impact of depth of response and early tumour shrinkage in patients with <i>BRAF</i> <sup></sup> -mutated metastatic colorectal cancer treated with targeted therapyGuglielmo Vetere, Marco Maria Germani, Carlotta Antoniotti, et al.
International Journal of Colorectal Disease|May 9, 2020
The treatment paradigm of right-sided metastatic colon cancer: harboring BRAF mutation makes the differenceMichela Roberto, Paolo Marchetti, Giulia Arrivi, et al.
Cancers|September 3, 2020
Evaluation of Prognostic Factors for Survival in Transverse Colon CancerMichela Roberto, Giulia Arrivi, Francesca Lo Bianco, et al.
Current Oncology (Toronto, Ont.)|June 27, 2023
Treatment Settings and Outcomes with Regorafenib and Trifluridine/Tipiracil at Third-Line Treatment and beyond in Metastatic Colorectal Cancer: A Real-World Multicenter Retrospective StudyCarlo Signorelli, Maria Alessandra Calegari, Michele Basso, et al.
Clinical Colorectal Cancer|January 24, 2025
Aflibercept-Based and Bevacizumab-Based Second Line Regimens in Patients with Metastatic Colorectal Cancer: Propensity Score Weighted-Analysis from a Multicenter CohortJessica Lucchetti, Lorenzo Angotti, Alessandro Parisi, et al.
Pageof 9